X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
https://generics.pharmaintelligence.informa.com/GB151320/Padagis-Starts-Life-Post-Perrigo-With-Eucrisa-Challenge
https://www.prnewswire.com/news-releases/padagis-confirms-first-to-file-patent-challenge-for-generic-version-of-eucrisa-301387193.html
https://www.ema.europa.eu/en/documents/overview/staquis-epar-medicine-overview_en.pdf
https://www.businesswire.com/news/home/20200324005177/en/U.S.-FDA-Approves-Supplemental-New-Drug-Application/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
http://www.pharmatimes.com/news/givlaari,_nubeqa_among_jan_chmp_decisions_1323999
https://www.fiercepharma.com/marketing/hey-big-spenders-pharma-ranks-top-five-industries-for-tv-media-spending-says-report
https://endpts.com/going-deeper-into-the-ezcema-game-novartis-orchestrates-1-1b-deal-for-a-morphosys-galapagos-drug/?utm_medium=email&utm_campaign=Thursday%20July%2019%202018&utm_content=Thursday%20July%2019%202018+CID_bdd4bf8da506fda4f826994e9420bffa&utm_source=ENDPOINTS%20emails&utm_term=Going%20deeper%20into%20the%20ezcema%20game%20Novartis%20orchestrates%2011B%20deal%20for%20a%20MorphoSysGalapagos%20drug
https://www.prnewswire.com/news-releases/growth-of-sanofi-regenerons-dupixent-in-atopic-dermatitis-may-be-facing-its-first-plateau-while-pfizers-eucrisa-carves-a-niche-with-younger-patients-300592851.html
http://www.fiercepharma.com/marketing/pfizer-launches-first-work-for-eucrisa-it-capitalizing-early-advantage-new-eczema
Market Place
Share 
